Combined cervical and vaginal reconstruction with prefabricated pudendal thigh flap in a case with cervical and vaginal agenesis (MURCS syndrome): a new and original technique.

Gürlek A, Aslan SS, Firat C, Ozturk-Ersoz A, Burak F.

Ann Plast Surg. 2008 Jul;61(1):88-93. doi: 10.1097/SAP.0b013e31815799d7.

Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial.

Simsek M, Burak F, Taskin O.

Clin Exp Obstet Gynecol. 2007;34(2):96-8.

Acute abdomen in a case with noncommunicating rudimentary horn and unicornuate uterus.

Atmaca R, Germen AT, Burak F, Kafkasli A.

JSLS. 2005 Apr-Jun;9(2):235-7.

Priming effect of misoprostol on estrogen pretreated cervix in postmenopausal women.

Atmaca R, Kafkasli A, Burak F, Germen AT.

Tohoku J Exp Med. 2005 Jul;206(3):237-41.

Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia.

Karabulut AB, Kafkasli A, Burak F, Gozukara EM.

Cell Biochem Funct. 2005 Jul-Aug;23(4):279-83.

Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol.

Meydanli MM, Calişkan E, Burak F, Narin MA, Atmaca R.

Int J Gynaecol Obstet. 2003 Jun;81(3):249-55.

Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery.

Taskin O, Sadik S, Onoglu A, Gokdeniz R, Erturan E, Burak F, Wheeler JM.

J Am Assoc Gynecol Laparosc. 2000 Aug;7(3):351-4.

Normal pregnancy outcome after inadvertent exposure to long-acting gonadotrophin-releasing hormone agonist in early pregnancy.

Taskin O, Gokdeniz R, Atmaca R, Burak F.

Hum Reprod. 1999 May;14(5):1368-71.

Adhesion formation after microlaparoscopic and laparoscopic ovarian coagulation for polycystic ovary disease.

Taskin O, Sadik S, Onoglu A, Gokdeniz R, Yilmaz I, Burak F, Wheeler JM.

J Am Assoc Gynecol Laparosc. 1999 May;6(2):159-63.

Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome.

Taskin O, Gökdeniz R, Yalcinoglu A, Buhur A, Burak F, Atmaca R, Ozekici U.

Hum Reprod. 1998 Sep;13(9):2402-5.

The effects of twisted ischaemic adnexa managed by detorsion on ovarian viability and histology: an ischaemia-reperfusion rodent model.

Taskin O, Birincioglu M, Aydin A, Buhur A, Burak F, Yilmaz I, Wheeler JM.

The effects of duration of CO2 insufflation and irrigation on peritoneal microcirculation assessed by free radical scavengers and total glutathion levels during operative laparoscopy.

Taskin O, Buhur A, Birincioglu M, Burak F, Atmaca R, Yilmaz I, Wheeler JM.

J Am Assoc Gynecol Laparosc. 1998 May;5(2):129-33.

Endometrial Na+, K+-ATPase pump function and vasopressin levels during hysteroscopic surgery in patients pretreated with GnRH agonist.

Taskin O, Buhur A, Birincioglu M, Burak F, Atmaca R, Yilmaz I, Wheeler JM.

J Am Assoc Gynecol Laparosc. 1998 May;5(2):119-24.

Side effects of tamoxifen in oophorectomized rats.

Kafkasli A, Erdem F, Müezzinoglu B, Akbaşak B, Burak F, Aksoy T, Birincioglu M, Biotech MG, Biotec FT.

Gynecol Obstet Invest. 1998;45(2):93-8.

Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.

Taskin O, Yalcinoglu AI, Kucuk S, Uryan I, Buhur A, Burak F.

Fertil Steril. 1997 Jan;67(1):40-5.

Effectiveness and Long-Term Safety of Prolonged Gosereline and Tibolone in Women with Endometriosis

Uryan I I, Taskin O, Erden F, Buhur A, Burak F, Ozekici U, Wheeler JM.

J Am Assoc Gynecol Laparosc. 1996 Aug;3(4, Supplement):S51-2.

The Effects of Daflon on Pelvic Pain in Women with Taylor Syndrome

Taskin O, Uryan I I, Buhur A, Burak F, Erden F, Atmaca R, Wheeler M.

J Am Assoc Gynecol Laparosc. 1996 Aug;3(4, Supplement):S49.

The degree of fluid absorption during hysteroscopic surgery in patients pretreated with goserelin.

Taskin O, Yalcinoglu A, Kucuk S, Burak F, Ozekici U, Wheeler JM.

J Am Assoc Gynecol Laparosc. 1996 Aug;3(4):555-9.

Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.

Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U.

Fertil Steril. 1996 Jun;65(6):1115-8.